222 related articles for article (PubMed ID: 36982297)
21. Colchicine protects dopaminergic neurons in a rat model of Parkinson's disease.
Salama M; Ellaithy A; Helmy B; El-Gamal M; Tantawy D; Mohamed M; Sheashaa H; Sobh M; Arias-Carrión O
CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):836-43. PubMed ID: 23198691
[TBL] [Abstract][Full Text] [Related]
22. Benefits of betanin in rotenone-induced Parkinson mice.
Thong-Asa W; Jedsadavitayakol S; Jutarattananon S
Metab Brain Dis; 2021 Dec; 36(8):2567-2577. PubMed ID: 34436745
[TBL] [Abstract][Full Text] [Related]
23. The Protective Effects of Mogroside V Against Neuronal Damages by Attenuating Mitochondrial Dysfunction via Upregulating Sirtuin3.
Luo H; Peng C; Xu X; Peng Y; Shi F; Li Q; Dong J; Chen M
Mol Neurobiol; 2022 Apr; 59(4):2068-2084. PubMed ID: 35040040
[TBL] [Abstract][Full Text] [Related]
24. Glycyrrhizic acid Attenuates Neuroinflammation and Oxidative Stress in Rotenone Model of Parkinson's Disease.
Ojha S; Javed H; Azimullah S; Abul Khair SB; Haque ME
Neurotox Res; 2016 Feb; 29(2):275-87. PubMed ID: 26607911
[TBL] [Abstract][Full Text] [Related]
25. Erinacine A Prevents Lipopolysaccharide-Mediated Glial Cell Activation to Protect Dopaminergic Neurons against Inflammatory Factor-Induced Cell Death In Vitro and In Vivo.
Lee SL; Hsu JY; Chen TC; Huang CC; Wu TY; Chin TY
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054997
[No Abstract] [Full Text] [Related]
26. Potential neuroprotective effect of androst-5-ene-3β, 17β-diol (ADIOL) on the striatum, and substantia nigra in Parkinson's disease rat model.
Salama RM; Tadros MG; Schaalan MF; Bahaa N; Abdel-Tawab AM; Khalifa AE
J Cell Physiol; 2018 Aug; 233(8):5981-6000. PubMed ID: 29266208
[TBL] [Abstract][Full Text] [Related]
27. Rotenone induces regionally distinct α-synuclein protein aggregation and activation of glia prior to loss of dopaminergic neurons in C57Bl/6 mice.
Rocha SM; Bantle CM; Aboellail T; Chatterjee D; Smeyne RJ; Tjalkens RB
Neurobiol Dis; 2022 Jun; 167():105685. PubMed ID: 35257879
[TBL] [Abstract][Full Text] [Related]
28. Novel anti-apoptotic L-DOPA precursors SuperDopa and SuperDopamide as potential neuroprotective agents for halting/delaying progression of Parkinson's disease.
Wiesen T; Atlas D
Cell Death Dis; 2022 Mar; 13(3):227. PubMed ID: 35277478
[TBL] [Abstract][Full Text] [Related]
29. Fenofibrate promotes neuroprotection in a model of rotenone-induced Parkinson's disease.
Barbiero JK; Ramos DC; Boschen S; Bassani T; Da Cunha C; Vital MABF
Behav Pharmacol; 2022 Dec; 33(8):513-526. PubMed ID: 36094044
[TBL] [Abstract][Full Text] [Related]
30. Modulatory Role of Nurr1 Activation and Thrombin Inhibition in the Neuroprotective Effects of Dabigatran Etexilate in Rotenone-Induced Parkinson's Disease in Rats.
Kandil EA; Sayed RH; Ahmed LA; Abd El Fattah MA; El-Sayeh BM
Mol Neurobiol; 2018 May; 55(5):4078-4089. PubMed ID: 28585189
[TBL] [Abstract][Full Text] [Related]
31. Astragaloside IV Inhibits Rotenone-Induced α-syn Presentation and the CD4 T-Cell Immune Response.
Wang M; Sun F; Han X; Wang N; Liu Y; Cai J; Tong S; Wang R; Wang H
Mol Neurobiol; 2024 Jan; 61(1):252-265. PubMed ID: 37603153
[TBL] [Abstract][Full Text] [Related]
32. The neuroprotective effects of hydro-alcoholic extract of olive (Olea europaea L.) leaf on rotenone-induced Parkinson's disease in rat.
Sarbishegi M; Charkhat Gorgich EA; Khajavi O; Komeili G; Salimi S
Metab Brain Dis; 2018 Feb; 33(1):79-88. PubMed ID: 29039078
[TBL] [Abstract][Full Text] [Related]
33. 1α,25-Dihydroxyvitamin D3 (VD3) Shows a Neuroprotective Action Against Rotenone Toxicity on PC12 Cells: An In Vitro Model of Parkinson's Disease.
de Siqueira EA; Magalhães EP; de Assis ALC; Sampaio TL; Lima DB; Marinho MM; Martins AMC; de Andrade GM; de Barros Viana GS
Neurochem Res; 2023 Jan; 48(1):250-262. PubMed ID: 36066698
[TBL] [Abstract][Full Text] [Related]
34. Role of L-thyroxin in counteracting rotenone induced neurotoxicity in rats.
Salama M; Helmy B; El-Gamal M; Reda A; Ellaithy A; Tantawy D; Mohamed M; El-Gamal A; Sheashaa H; Sobh M
Environ Toxicol Pharmacol; 2013 Mar; 35(2):270-7. PubMed ID: 23357603
[TBL] [Abstract][Full Text] [Related]
35. DJ-1 protects dopaminergic neurons against rotenone-induced apoptosis by enhancing ERK-dependent mitophagy.
Gao H; Yang W; Qi Z; Lu L; Duan C; Zhao C; Yang H
J Mol Biol; 2012 Oct; 423(2):232-48. PubMed ID: 22898350
[TBL] [Abstract][Full Text] [Related]
36. Benefits of p-coumaric acid in mice with rotenone-induced neurodegeneration.
Dolrahman N; Mukkhaphrom W; Sutirek J; Thong-Asa W
Metab Brain Dis; 2023 Jan; 38(1):373-382. PubMed ID: 36308586
[TBL] [Abstract][Full Text] [Related]
37. Apelin-13 Protects Dopaminergic Neurons against Rotenone-Induced Neurotoxicity through the AMPK/mTOR/ULK-1 Mediated Autophagy Activation.
Chen P; Wang Y; Chen L; Song N; Xie J
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171641
[TBL] [Abstract][Full Text] [Related]
38. Phenothiazine normalizes the NADH/NAD
Tapias V; McCoy JL; Greenamyre JT
Redox Biol; 2019 Jun; 24():101164. PubMed ID: 30925294
[TBL] [Abstract][Full Text] [Related]
39. The neuroprotective action of lenalidomide on rotenone model of Parkinson's Disease: Neurotrophic and supportive actions in the substantia nigra pars compacta.
Cankara FN; Günaydın C; Bilge SS; Özmen Ö; Kortholt A
Neurosci Lett; 2020 Nov; 738():135308. PubMed ID: 32932183
[TBL] [Abstract][Full Text] [Related]
40. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]